This is a non binding agreement. Not even worth the paper it's written on. If directors aren't buying up at this price you know it's a dud company. Hope for all you bulls they are buying
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game